| Burt Sookram, Vice President, Research & Development/Quality Assurance
George Merrell, Plant Manager
ST. PETERSBURG, Fla., Feb. 25 -- Nutraceutical
Clinical Laboratories International, Inc. (OTC: NCCL) today announced the
appointments of Mr. Burt Sookram as Vice President, Research &
Development/Quality Assurance and Mr. George Merrell, Plant Manager.
Burt Sookram, Special Projects Manager for United Beverage Group, brings
years of experience to a host of leadership roles throughout a distinguished
career in the food industry. Previously, he served as president of BAIT
Corporation and Catalina Food Ingredients, Inc. Mr. Sookram was General
Manager of FlavorTech, a division of Sara Lee. His extensive experience
includes research and development, operational management, procurement,
quality assurance, total quality management and sales. Mr. Sookram has
developed several products for bakery, seafood, sport drinks, snack food
seasoning, meats and the pizza industry sold in today's marketplace.
Mr. Sookram received his BS and MS in Chemistry from the University of
Toronto, Canada.
George Merrell, Plant Manager for KIK International f.k.a., The Dial
Corporation, has over twenty years of progressive, management experience.
Within the consumer products industry, Mr. Merrell has had direct
responsibility for manufacturing, safety, quality, engineering, maintenance,
and human resources.
Mr. Merrell received a Bachelor Arts in Social Science from Edinboro,
University of Pennsylvania.
For complete biographical sketches on Mr. Sookram and Mr. Merrell, click
on http://www.nutradata.com .
Paul Simmons, CEO, states, "We are extremely happy to welcome these two
gentlemen to our staff. Their expertise and experience will enable us to ramp
up our production to meet the demanding expectations of our customers."
About NCLII
NCLII is committed to researching, designing, producing, and marketing
their line of natural preservatives and anti-aging supplements using the
highest quality standards, procedures, protocols, and controls. Our products
will be manufactured according to the Food and Drug Administration (FDA)
criteria for Good Manufacturing Practices (GMP) and will be backed by thorough
scientific testing and clinical trials.
Nutraceutical Clinical Laboratories International, Inc. trades on the OTC
market under the symbol "NCCL" and can be found on the Internet at:
nasdaq.com , cnbc.com , pinksheets.com , and otcquote.com . Additional
company information may be found at Nutraceutical Clinical Laboratories
International, Inc.'s website: www.nutradata.com .
Special note: Forward looking statements in this press release are made
pursuant to the "safe harbor" provision of the Private Securities Litigation
Act of 1995. Investors are cautioned that such forward looking statements
involve risks and uncertainties, including without limitation, market
acceptance of, demand for, the Company's products, manufacturing, development
and distribution issues, product pricing, competition, technological changes
and other risks not identified herein.
|